½ÃÀ庸°í¼­
»óǰÄÚµå
1591972

¼¼°èÀÇ ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°, º¸Á¤ Àü·«, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Image-guided Therapy System Market by Product (Computed Tomography Imaging, Intervention X-ray, Magnetic Resonance Imaging), Correction Strategy (Offline, On Line), Application, End User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 199 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¿µ»óÀ¯µµÄ¡·á½Ã½ºÅÛ ½ÃÀåÀº 2023³â¿¡ 44¾ï 6,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 47¾ï 9,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.27%·Î ¼ºÀåÇØ 2030³â¿¡´Â 73¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ(IGTS)Àº ¿µ»ó±â¼ú°ú Ä¡·á±â¼úÀÌ °íµµ·Î ±³Â÷ÇÑ °ÍÀ¸·Î, ¼ö¼ú°ú Ä¡·á󸮿¡ Á¤È®ÇÑ °³ÀÔÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ¼ö¼ú Áß ½Ç½Ã°£ À̹ÌÁö µ¥ÀÌÅ͸¦ Á¦°øÇÔÀ¸·Î½á ³·Àº ħ½À ¼ö¼úÀ» °¡´ÉÇÏ°Ô Çϰí, ȯÀÚ °á°ú¸¦ °³¼±Çϸç, ȸº¹ ½Ã°£À» ´ÜÃàÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ±× Çʿ伺Àº ½Å°æÇÐ, ½ÉÀ庴ÇÐ, Á¤Çü¿Ü°ú, Á¾¾çÇÐ µî ´Ù¾çÇÑ ÀÇ·á ºÐ¾ß¿¡¼­ Á¤È®Çϰí È¿°úÀûÀ̸ç ħ½À¼ºÀÌ ³·Àº Ä¡·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¹ß»ýÇÕ´Ï´Ù. ÃÖÁ¾ ¿ëµµ´Â º´¿ø, Áø·á¼Ò, ¿Ü°ú ¼ö¼ú ´É·ÂÀÇ Çâ»óÀ» ¸ñÇ¥·Î ÇÏ´Â ¿¬±¸ ±â°ü¿¡±îÁö ÆÛÁ® ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¸¸¼º ÁúȯÀÇ À¯º´·ü »ó½Â, ħ½À¼ºÀÌ ³·Àº ÀÇ·á óġ¸¦ ¿ä±¸ÇÏ´Â °í·ÉÈ­, MRI, CT ½ºÄµ, ÃÊÀ½ÆÄ µîÀÇ ¿µ»ó Áø´Ü ¾ç½ÄÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸°¡ ¼ºÀåÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É°ú ¸Ó½Å·¯´× ¾ÖÇø®ÄÉÀ̼ÇÀº µ¥ÀÌÅÍÀÇ Á¤È®¼º°ú ó¸® È¿À²¼ºÀ» ³ôÀÌ´Â ÀáÀçÀûÀÎ ±âȸ¸¦ ²ø¾î³»°í ÀÖ½À´Ï´Ù. ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â ÀÇ·á ÀÎÇÁ¶ó ÅõÀÚ Áõ°¡, ¼±Áø Ä¡·á ±â¼ú¿¡ ´ëÇÑ Á¤ºÎ ¿ì´ë Á¶Ä¡, Á¤¹ÐÀÇ·á¿¡¼­ÀÇ ¿¬±¸ °³¹ß È®´ë µîÀÌ ÀÖ½À´Ï´Ù. ±×·³¿¡µµ ºÒ±¸ÇϰíÀÌ ½ÃÀåÀº ÀåÄ¡ÀÇ °íºñ¿ë, Àü¹® ±â¼úÀÌ ÇÊ¿äÇÑ ÀýÂ÷ÀÇ º¹À⼺, ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æ µîÀÇ Á¦¾à¿¡ Á÷¸éÇϰí ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ¹®Á¦´Â µðÁöÅÐ ÅëÇÕ ½Ã½ºÅÛ°ú °ü·ÃµÈ »çÀ̹ö º¸¾È À§Çè°ú »óÈ£ ¿î¿ë¼º ¹®Á¦ µîÀÔ´Ï´Ù. ºñ¿ë È¿À²ÀûÀÎ ÈÞ´ë¿ë IGTS ¼Ö·ç¼Ç °³¹ß°ú ¿¹Ãø ÅëÂû·ÂÀ» À§ÇÑ °í±Þ AI ÁÖµµ ºÐ¼®ÀÇ ÅëÇÕ¿¡´Â Çõ½ÅÀûÀÎ ±âȸ°¡ Á¸ÀçÇÕ´Ï´Ù. ¶ÇÇÑ ½Ç½Ã°£ 3D À̹ÌÁö ó¸® ¹× Áõ°­Çö½Ç(AR)ÀÇ È¹±âÀûÀÎ Áøº¸´Â ¼ö¼ú Áö¿ø¿¡ ´õ¿í Çõ¸íÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ±×¸®°í Áøº¸ µÈ ÀÇ·á ±â¼ú¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇϰíÀÖ´Â ½ÅÈï ½ÃÀå¿¡ ÁßÁ¡À» µÓ´Ï´Ù. ±×¸®°í ÀÌ·¯ÇÑ ±âȸ¸¦ Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. °úÁ¦´Â ÀÖ´Â °Í, ½ÃÀåÀÇ ¿ªµ¿ÀûÀÎ ¼ºÁúÀº ȹ±âÀûÀÎ Áøº¸¸¦ ÀÌ·ê ¼ö ÀÖ´Â Å« °¡´É¼ºÀ» ³ªÅ¸³»°í ÀÖÀ¸¸ç, Áö¼ÓÀûÀÎ Çõ½Å°ú »õ·Î¿î ±â¼ú µ¿Çâ ¹× °Ç°­ °ü¸® ¿ä±¸¿¡ ´ëÇÑ Àü·«Àû ÀûÀÀÀÇ Á߿伺À» °­Á¶ÇÕ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 44¾ï 6,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 47¾ï 9,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 73¾ï ´Þ·¯
CAGR(%) 7.27%

½ÃÀå ¿ªÇÐ: ±Þ¼ÓÈ÷ ÁøÈ­ÇÏ´Â ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ¼¼·ÃµÇ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°Í Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º ÁúȯÀÇ À¯º´·ü »ó½Â¿¡ ¼ö¹ÝÇÏ´Â ³ëÀÎ Àα¸ Áõ°¡
    • Àúħ½À ¼ö¼ú¿¡ÀÇ ±âÈ£ÀÇ º¯È­
    • ¾Ï ¹æ»ç¼± Ä¡·á¿¡ ´ëÇÑ ´ëó °Ç¼ö Áõ°¡
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ°ú °ü·ÃµÈ Ãʱ⠺ñ¿ëÀÇ ³ôÀÌ
  • ½ÃÀå ±âȸ
    • ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸
    • Àü·«Àû Á¦ÈÞ¿Í ÅõÀÚ Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ¹ë¸®µ¥ÀÌ¼Ç ±Ô°Ý°ú µð¹ÙÀ̽º ÀÎÅÍÆäÀ̽º ±Ô°Ý

Porter's Five Forces: ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¹ýÀ» Á¦°øÇÕ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù.ÀÇ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸ Á¦°ø PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¾ÕÀ¸·Î ¿¹»óÇÑ Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. Æ÷Áö¼Å´× ºÎµå·´°Ô ÇÒ ¼ö ÀÖ½À´Ï´Ù.ÀÌ ºÐ¼®Àº ½ÃÀå ÁýÁß, ´ÜÆíÈ­ ¹× ÅëÇÕ µ¿ÇâÀ» ¸íÈ®È÷ÇÏ°í º¥´õ´Â °æÀïÀÌ Ä¡¿­ ÇØÁü¿¡ µû¶ó ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÕ´Ï´Ù. Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Á¤º¸¸¦ ±â¹ÝÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ °æ·Î¸¦ ±×¸³´Ï´Ù.

¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀåÀÇ Àü·«ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö ÀÖ´Â ½Ã½ºÅÛÀ» ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º ÁúȯÀÇ À¯º´·üÀÇ »ó½Â¿¡ ¼ö¹ÝÇÏ´Â °í·ÉÀÚ Àα¸ Áõ°¡
      • Àúħ½À ¼ö¼ú¿¡ ´ëÇÑ ÃëÇâÀÇ º¯È­
      • ¾Ï ¹æ»ç¼± Ä¡·áÀÇ ´ëó°¡ Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ°ú °ü·ÃµÈ Ãʱ⠺ñ¿ëÀÌ ³ô´Ù
    • ±âȸ
      • ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ¿¡¼­ÀÇ Áö¼ÓÀûÀÎ ±â¼ú Áøº¸
      • Àü·«Àû Á¦ÈÞ¿Í ÅõÀÚ Áõ°¡
    • °úÁ¦
      • °ËÁõ Ç¥ÁØ ¹× µð¹ÙÀ̽º ÀÎÅÍÆäÀ̽º Ç¥ÁØ
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : Á¦Ç°º°

  • ÄÄÇ»ÅÍ ´ÜÃþ ÃÔ¿µ À̹ÌÁö
  • °³ÀÔ X¼±
  • Àڱ⠰ø¸í È­»ó
  • ¾çÀüÀÚ ¹æÃâ ´ÜÃþ ÃÔ¿µ
  • ÃÊÀ½ÆÄ ½Ã½ºÅÛ

Á¦7Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ¼öÁ¤ Àü·«º°

  • ¿ÀÇÁ¶óÀÎ
  • ¿Â¶óÀÎ

Á¦8Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ¿ëµµº°

  • ¼ÒÈ­±â ³»°ú
  • ³ú½Å°æ¿Ü°ú
  • Á¾¾çÇÐ
  • Á¤Çü¿Ü°ú

Á¦9Àå ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø
  • Á¶»ç ¹× Çмú±â°ü

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ¿µ»ó À¯µµ Ä¡·á ½Ã½ºÅÛ ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Abbott Laboratories
  • Analogic Corporation
  • Brainlab AG
  • Canon Medical Systems Corporation
  • Elekta AB
  • FUJIFILM Holdings Corporation
  • GE Healthcare
  • Hitachi, Ltd.
  • KARL STORZ SE & Co. KG
  • Koninklijke Philips NV
  • Medtronic PLC
  • Olympus Corporation
  • Siemens Healthineers AG
  • Stryker Corporation
  • Toshiba Corporation
  • Varian Medical Systems, Inc.
JHS 24.11.26

The Image-guided Therapy System Market was valued at USD 4.46 billion in 2023, expected to reach USD 4.79 billion in 2024, and is projected to grow at a CAGR of 7.27%, to USD 7.30 billion by 2030.

Image-guided therapy systems (IGTS) represent an advanced intersection of imaging and therapeutic technologies, providing precise interventions in surgical and therapeutic procedures. These systems are crucial in enabling minimally invasive surgeries, improving patient outcomes, and reducing recovery times by providing real-time imaging data during procedures. The necessity arises from the increased demand for accurate, effective, and less invasive treatments across various medical fields, including neurology, cardiology, orthopedics, and oncology. End-use extends to hospitals, clinics, and research institutions seeking to enhance their surgical capabilities. The market is poised for growth driven by the rising prevalence of chronic diseases, an aging population demanding less invasive medical procedures, and continuous technological advancements in imaging modalities such as MRI, CT scans, and ultrasound. Furthermore, artificial intelligence and machine learning applications are unlocking potential opportunities for enhanced data accuracy and procedure efficiency. Key growth factors also include increasing healthcare infrastructure investments, government incentives for advanced therapeutic technologies, and expanding R&D in precision medicine. Nevertheless, the market faces limitations such as high costs of devices, procedural complexities requiring specialized skills, and stringent regulatory environments. Ongoing challenges include cybersecurity risks associated with digitally integrated systems and interoperability issues. Opportunities for innovation exist in developing cost-effective, portable IGTS solutions and integrating advanced AI-driven analytics for predictive insights. Additionally, breakthroughs in real-time 3D imaging and augmented reality can further revolutionize surgical assistance. Businesses can capitalize on these opportunities by investing in partnerships with tech companies, enhancing R&D capabilities, and focusing on emerging markets where the demand for advanced medical technology is increasing. Despite challenges, the market's dynamic nature indicates significant potential for breakthroughs, underscoring the importance of continuous innovation and strategic adaptation to emerging technological trends and healthcare needs.

KEY MARKET STATISTICS
Base Year [2023] USD 4.46 billion
Estimated Year [2024] USD 4.79 billion
Forecast Year [2030] USD 7.30 billion
CAGR (%) 7.27%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Image-guided Therapy System Market

The Image-guided Therapy System Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in the geriatric population with rising prevalence rate of chronic conditions
    • Shifting preference for minimally invasive surgeries
    • Rising in the number of initiatives for cancer radiotherapy
  • Market Restraints
    • High initial cost associated with image-guided therapy system
  • Market Opportunities
    • Ongoing technological advancements in image-guided therapy system
    • Increasing strategic alliances and investments
  • Market Challenges
    • Validation standards and device interface standards

Porter's Five Forces: A Strategic Tool for Navigating the Image-guided Therapy System Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Image-guided Therapy System Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Image-guided Therapy System Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Image-guided Therapy System Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Image-guided Therapy System Market

A detailed market share analysis in the Image-guided Therapy System Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Image-guided Therapy System Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Image-guided Therapy System Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Image-guided Therapy System Market

A strategic analysis of the Image-guided Therapy System Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Image-guided Therapy System Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Analogic Corporation, Brainlab AG, Canon Medical Systems Corporation, Elekta AB, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., KARL STORZ SE & Co. KG, Koninklijke Philips N.V., Medtronic PLC, Olympus Corporation, Siemens Healthineers AG, Stryker Corporation, Toshiba Corporation, and Varian Medical Systems, Inc..

Market Segmentation & Coverage

This research report categorizes the Image-guided Therapy System Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Computed Tomography Imaging, Intervention X-ray, Magnetic Resonance Imaging, Positron Emission Tomography, and Ultrasound Systems.
  • Based on Correction Strategy, market is studied across Offline and On Line.
  • Based on Application, market is studied across Gastroenterology, Neurosurgery, Oncology, and Orthopedic Surgery.
  • Based on End User, market is studied across Ambulatory Surgery Centers, Clinics, Hospitals, and Research & Academic Institutes.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in the geriatric population with rising prevalence rate of chronic conditions
      • 5.1.1.2. Shifting preference for minimally invasive surgeries
      • 5.1.1.3. Rising in the number of initiatives for cancer radiotherapy
    • 5.1.2. Restraints
      • 5.1.2.1. High initial cost associated with image-guided therapy system
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing technological advancements in image-guided therapy system
      • 5.1.3.2. Increasing strategic alliances and investments
    • 5.1.4. Challenges
      • 5.1.4.1. Validation standards and device interface standards
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Image-guided Therapy System Market, by Product

  • 6.1. Introduction
  • 6.2. Computed Tomography Imaging
  • 6.3. Intervention X-ray
  • 6.4. Magnetic Resonance Imaging
  • 6.5. Positron Emission Tomography
  • 6.6. Ultrasound Systems

7. Image-guided Therapy System Market, by Correction Strategy

  • 7.1. Introduction
  • 7.2. Offline
  • 7.3. On Line

8. Image-guided Therapy System Market, by Application

  • 8.1. Introduction
  • 8.2. Gastroenterology
  • 8.3. Neurosurgery
  • 8.4. Oncology
  • 8.5. Orthopedic Surgery

9. Image-guided Therapy System Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgery Centers
  • 9.3. Clinics
  • 9.4. Hospitals
  • 9.5. Research & Academic Institutes

10. Americas Image-guided Therapy System Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Image-guided Therapy System Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Image-guided Therapy System Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Analogic Corporation
  • 3. Brainlab AG
  • 4. Canon Medical Systems Corporation
  • 5. Elekta AB
  • 6. FUJIFILM Holdings Corporation
  • 7. GE Healthcare
  • 8. Hitachi, Ltd.
  • 9. KARL STORZ SE & Co. KG
  • 10. Koninklijke Philips N.V.
  • 11. Medtronic PLC
  • 12. Olympus Corporation
  • 13. Siemens Healthineers AG
  • 14. Stryker Corporation
  • 15. Toshiba Corporation
  • 16. Varian Medical Systems, Inc.
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦